FMP

FMP

Enter

INSM - Insmed Incorporated

Financial Summary of Insmed Incorporated(INSM), Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients

photo-url-https://financialmodelingprep.com/image-stock/INSM.png

Insmed Incorporated

INSM

NASDAQ

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

57.96 USD

4.41 (7.61%)

About

ceo

Mr. William H. Lewis J.D., M.B.A.

sector

Healthcare

industry

Biotechnology

website

https://www.insmed.com

exchange

NASDAQ

Description

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated ...

CIK

0001104506

ISIN

US4576693075

CUSIP

457669307

Address

700 US Highway 202/206

Phone

908 977 9900

Country

US

Employee

912

IPO Date

Jun 1, 2000

Summary

CIK

0001104506

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

457669307

ISIN

US4576693075

Country

US

Price

57.96

Beta

0.93

Volume Avg.

2.47M

Market Cap

8.61B

Shares

-

52-Week

18.77-58.81

DCF

25.32

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-11.08

P/B

-

Website

https://www.insmed.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest INSM News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep